Derivation of human trophoblast stem cells from placentas at birth
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Victoria Karakis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Trophoblasts, Stem Cells, Placenta. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Human trophoblast stem cells (hTSCs) have emerged as a powerful tool for modeling the placental cytotrophoblast (CTB) in vitro. hTSCs were originally derived from CTBs of the first-trimester placenta or blastocyst-stage embryos in trophoblast stem cell medium (TSCM) that contains epidermal growth factor, the glycogen synthase kinase-beta inhibitor CHIR99021, the transforming growth factor-beta inhibitors A83-01 and SB431542, valproic acid, and the Rho-associated protein kinase inhibitor Y-27632. Here, we show that hTSCs can be derived from CTBs isolated from the term placenta, using TSCM supplemented with a low concentration of mitochondrial pyruvate uptake inhibitor UK5099 and lipid-rich albumin (TUA medium). Notably, hTSCs could not be derived from term CTBs using TSCM alone, or in the absence of either UK5099 or lipid-rich albumin. Strikingly, hTSCs cultured in TUA medium for a few passages could be transitioned into TSCM and cultured thereafter in TSCM. hTSCs from term CTBs cultured in TUA medium as well as those transitioned into and cultured in TSCM thereafter could be differentiated to the extravillous trophoblast and syncytiotrophoblast lineages and exhibited high transcriptome similarity with hTSCs derived from first-trimester CTBs. We anticipate that these results will enable facile derivation of hTSCs from normal and pathological placentas at birth with diverse genetic backgrounds and facilitate in vitro mechanistic studies in trophoblast biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA; Golden LEAF Biomanufacturing Training and Education Center, North Carolina State University, Raleigh, N…
Förderung
- NICHD NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Child Health and Human Development
Zitieren
APA
Karakis, V., Britt, J. W., Jabeen, M., San Miguel, A., & Rao, B. M. (2025). Derivation of human trophoblast stem cells from placentas at birth. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108505
Vancouver
Karakis V, Britt JW, Jabeen M, San Miguel A, Rao BM. Derivation of human trophoblast stem cells from placentas at birth. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108505
BibTeX
@article{Karakis2025,
author = {Karakis, Victoria and Britt, John W and Jabeen, Mahe and San Miguel, Adriana and Rao, Balaji M},
title = {Derivation of human trophoblast stem cells from placentas at birth},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108505}
}
EUVIMED